Issue 2, 2015

Modeling the mitotic regulatory network identifies highly efficient anti-cancer drug combinations

Abstract

Targeting mitotic regulation is recognized as an important strategy for cancer therapy. Aurora A/B kinase and polo-like kinase 1 (PLK1) are the key mitotic regulators, and many inhibitors have been developed. Combinations of these inhibitors are anticipated to be more effective therapeutics compared with single-inhibitor treatments; however, a systematic analysis of the combined effects is lacking. Here, we constructed the first mammalian cell mitotic regulation network model, which spans from mitotic entry to anaphase initiation, and contains all key mitotic kinase targets. The combined effects of different kinase inhibitors and microtubule inhibitors were systematically explored. Simultaneous inhibition of Aurora B and PLK1 strongly induces polyploidy. Microtubule inhibitor dosage can be significantly reduced when combined with a PLK1 inhibitor. The efficacy of these inhibitor combinations was validated by our experimental results. The mitotic regulatory network model provides a platform to study the complex interactions during mitosis, enables identification of mitotic regulators, and determines targets for drug discovery research. The suggested use of combining microtubule inhibitors with PLK1 inhibitors is anticipated to enhance microtubule-inhibitor tolerance in a wide range of patients.

Graphical abstract: Modeling the mitotic regulatory network identifies highly efficient anti-cancer drug combinations

Supplementary files

Article information

Article type
Paper
Submitted
14 Oct 2014
Accepted
10 Nov 2014
First published
10 Nov 2014

Mol. BioSyst., 2015,11, 497-505

Modeling the mitotic regulatory network identifies highly efficient anti-cancer drug combinations

Y. Wu, X. Zhuo, Z. Dai, X. Guo, Y. Wang, C. Zhang and L. Lai, Mol. BioSyst., 2015, 11, 497 DOI: 10.1039/C4MB00610K

To request permission to reproduce material from this article, please go to the Copyright Clearance Center request page.

If you are an author contributing to an RSC publication, you do not need to request permission provided correct acknowledgement is given.

If you are the author of this article, you do not need to request permission to reproduce figures and diagrams provided correct acknowledgement is given. If you want to reproduce the whole article in a third-party publication (excluding your thesis/dissertation for which permission is not required) please go to the Copyright Clearance Center request page.

Read more about how to correctly acknowledge RSC content.

Spotlight

Advertisements